30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Calithera Biosciences Inc (CALA)

Track

Stock chart
Ticker: CALA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
PAKIANATHAN DEEPIKA
2 sales — total 46,810 USD
Sale 27 Jan 2023
Value US$2,322,813.41 | Price 173.18 | Shares 14,344
Sale 27 Jan 2023
Value US$3,945,610.85 | Price 383.51 | Shares 21,878
Sale 11 Nov 2021
Value US$2,668,114.80 | Price 430.53 | Shares 17,863
Sale 10 Nov 2021
Value US$25,695.00 | Price 0.86 | Shares 30,000
Buy 10 Nov 2021
Value US$171,900.00 | Price 0.86 | Shares 200,000
Buy 10 Nov 2021
Value US$84,670.00 | Price 0.85 | Shares 100,000
Buy 10 Nov 2021
Value US$84,670.00 | Price 0.85 | Shares 100,000
Sale 9 Nov 2021
Value US$43,520.40 | Price 0.84 | Shares 51,810
Planned sale 16 Dec 2020
Value US$14,682.00 | Price 6.00 | Shares 2,447
Sale 21 May 2020
Value US$1,153,500.00 | Price 6.00 | Shares 192,250
Sale 21 May 2020
Value US$6,385,992.00 | Price 6.00 | Shares 1,064,332
Sale 21 May 2020
Value US$6,162,096.00 | Price 6.00 | Shares 1,027,016
Planned sale 15 Apr 2020
Value US$40,000.00 | Price 8.00 | Shares 5,000
Planned sale 20 Feb 2020
Value US$24,168.00 | Price 8.00 | Shares 3,021
Planned sale 23 Dec 2019
Value US$18,126.00 | Price 6.00 | Shares 3,021
Buy 20 Nov 2019
Value US$55,353.05 | Price 3.91 | Shares 14,151
Buy 20 Nov 2019
Value US$310,131.21 | Price 3.91 | Shares 79,285
Buy 20 Nov 2019
Value US$385,363.01 | Price 3.91 | Shares 98,518
Buy 14 Nov 2019
Value US$37,423.85 | Price 3.37 | Shares 11,105
Buy 14 Nov 2019
Value US$154,642.56 | Price 3.37 | Shares 45,888
Buy 14 Nov 2019
Value US$240,938.15 | Price 3.37 | Shares 71,495
Buy 30 Oct 2019
Value US$156,243.60 | Price 2.70 | Shares 57,868
Buy 30 Oct 2019
Value US$893,829.60 | Price 2.70 | Shares 331,048
Buy 30 Oct 2019
Value US$1,103,198.40 | Price 2.70 | Shares 408,592
Buy 29 Oct 2019
Value US$303,035.20 | Price 2.60 | Shares 116,552
Buy 29 Oct 2019
Value US$1,586,135.20 | Price 2.60 | Shares 610,052
Buy 29 Oct 2019
Value US$2,268,169.80 | Price 2.60 | Shares 872,373
Planned buy 25 Jun 2019
Value US$200,208.00 | Price 3.88 | Shares 51,600
Planned buy 25 Jun 2019
Value US$200,208.00 | Price 3.88 | Shares 51,600
Planned sale 17 Jun 2019
Value US$2,502.00 | Price 6.00 | Shares 417
Planned sale 22 May 2019
Value US$2,496.00 | Price 6.00 | Shares 416
Planned sale 15 Apr 2019
Value US$2,633.28 | Price 6.33 | Shares 416
Planned sale 15 Mar 2019
Value US$2,681.31 | Price 6.43 | Shares 417
Planned sale 11 Mar 2019
Value US$9,390.00 | Price 6.00 | Shares 1,565
Planned sale 15 Oct 2018
Value US$1,893.65 | Price 6.05 | Shares 313
Planned sale 11 Oct 2018
Value US$7,512.00 | Price 6.00 | Shares 1,252
Sale 28 Sep 2017
Value US$589,000.00 | Price 15.50 | Shares 38,000
Sale 27 Sep 2017
Value US$2,899,740.00 | Price 15.59 | Shares 186,000
Sale 26 Sep 2017
Value US$5,519,360.00 | Price 15.68 | Shares 352,000
Planned sale 17 Jul 2017
Value US$65,384.51 | Price 18.41 | Shares 3,552
Planned sale 17 Jul 2017
Value US$38,822.71 | Price 18.31 | Shares 2,120
Planned sale 6 Jul 2017
Value US$12,600.00 | Price 18.00 | Shares 700
Planned sale 19 May 2017
Value US$10,400.00 | Price 16.00 | Shares 650
Buy 22 Mar 2017
Value US$4,999,991.00 | Price 10.25 | Shares 487,804
Planned sale 13 Mar 2017
Value US$8,400.00 | Price 14.00 | Shares 600
Planned sale 2 Mar 2017
Value US$6,600.00 | Price 12.00 | Shares 550
Buy 16 Nov 2016
Value US$1,575,000.00 | Price 3.15 | Shares 500,000
Buy 23 Sep 2015
Value US$243,767.54 | Price 6.07 | Shares 40,168
Buy 22 Sep 2015
Value US$250,937.94 | Price 6.00 | Shares 41,800
Buy 22 Sep 2015
Value US$149,942.50 | Price 6.00 | Shares 25,000
Buy 4 Sep 2015
Value US$13,685.00 | Price 5.95 | Shares 2,300
Buy 3 Sep 2015
Value US$521,840.00 | Price 5.93 | Shares 88,000
Buy 28 Aug 2015
Value US$122,760.00 | Price 5.58 | Shares 22,000
Buy 28 Aug 2015
Value US$114,885.00 | Price 5.55 | Shares 20,700
Buy 27 Aug 2015
Value US$173,340.00 | Price 5.35 | Shares 32,400
Buy 27 Aug 2015
Value US$150,390.13 | Price 5.17 | Shares 29,089
Buy 27 Aug 2015
Value US$109,245.24 | Price 5.58 | Shares 19,578
Buy 27 Aug 2015
Value US$33,953.79 | Price 5.43 | Shares 6,253
Buy 27 Aug 2015
Value US$53,277.68 | Price 5.41 | Shares 9,848
Buy 26 Aug 2015
Value US$149,069.70 | Price 4.65 | Shares 32,058
Buy 26 Aug 2015
Value US$940.00 | Price 4.70 | Shares 200
Buy 15 Oct 2014
Value US$170,000.00 | Price 6.80 | Shares 25,000
Buy 15 Oct 2014
Value US$94,250.00 | Price 7.25 | Shares 13,000
Buy 14 Oct 2014
Value US$174,750.00 | Price 6.99 | Shares 25,000
Buy 14 Oct 2014
Value US$210,000.00 | Price 7.00 | Shares 30,000
Buy 13 Oct 2014
Value US$615,578.00 | Price 6.94 | Shares 88,700
Buy 7 Oct 2014
Value US$48,350.00 | Price 10.00 | Shares 4,835
Buy 7 Oct 2014
Value US$4,951,650.00 | Price 10.00 | Shares 495,165
Buy 7 Oct 2014
Value US$3,000,000.00 | Price 10.00 | Shares 300,000
Buy 7 Oct 2014
Value US$3,500,000.00 | Price 10.00 | Shares 350,000
Buy 7 Oct 2014
Value US$3,500,000.00 | Price 10.00 | Shares 350,000
Buy 7 Oct 2014
Value US$3,000,000.00 | Price 10.00 | Shares 300,000
Buy 7 Oct 2014
Value US$48,350.00 | Price 10.00 | Shares 4,835
Buy 7 Oct 2014
Value US$4,951,650.00 | Price 10.00 | Shares 495,165
Buy 1 Oct 2014
Value US$8,000,000.00 | Price 10.00 | Shares 800,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2023-01-31 2023-01-27 S Sale
4.0
PAKIANATHAN DEEPIKA
Non-Executive Director
14,344 -14.1%
173.18
US$2,322,813 		14,344 -14.1% 173.18 US$2,322,813
2023-01-31 2023-01-27 S Sale
4.0
PAKIANATHAN DEEPIKA
Non-Executive Director
21,878 +25.6%
383.51
US$3,945,611 		21,878 +25.6% 383.51 US$3,945,611
2021-11-12 2021-11-11 S Sale
Orford Keith

Director

Officer
17,863 -14.5%
430.53
US$2,668,115 		17,863 -14.5% 430.53 US$2,668,115
2021-11-12 2021-11-10 S Sale
Orford Keith

Director

Officer
30,000 -20.8%
0.86
US$25,695 		30,000 -20.8% 0.86 US$25,695
2021-11-10 2021-11-10 B Purchase
2.8
DRACHMAN JONATHAN G
Non-Executive Director
200,000 +inf%
0.86
US$171,900 		200,000 +inf% 0.86 US$171,900
2021-11-10 2021-11-10 B Purchase
Molineaux Christopher

SR. VP, DEVELOPMENT

Officer
100,000 +21.9%
0.85
US$84,670 		100,000 +21.9% 0.85 US$84,670
2021-11-10 2021-11-10 B Purchase
Molineaux Susan

PRESIDENT & CEO

Executive Director
100,000 +21.9%
0.85
US$84,670 		100,000 +21.9% 0.85 US$84,670
2021-11-09 2021-11-09 S Sale
Orford Keith
Non-Executive Director
51,810 -26.4%
0.84
US$43,520 		51,810 -26.4% 0.84 US$43,520
2020-12-18 2020-12-16 PlS Planned sale
Orford Keith

Chief Medical Officer

Officer
2,447 -18.1%
6.00
US$14,682 		2,447 -18.1% 6.00 US$14,682
2020-05-26 2020-05-21 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
192,250 -28.6%
6.00
US$1,153,500 		192,250 -28.6% 6.00 US$1,153,500
2020-05-26 2020-05-21 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
1,064,332 -27.8%
6.00
US$6,385,992 		1,064,332 -27.8% 6.00 US$6,385,992
2020-05-26 2020-05-21 S Sale
4.0
BVF PARTNERS L P/IL
Large shareholder
1,027,016 -21.7%
6.00
US$6,162,096 		1,027,016 -21.7% 6.00 US$6,162,096
2020-04-17 2020-04-15 PlS Planned sale
Wong Stephanie

SR. VP, FINANCE & SECRETARY

Officer
5,000 -14.3%
8.00
US$40,000 		5,000 -14.3% 8.00 US$40,000
2020-02-24 2020-02-20 PlS Planned sale
Orford Keith

Chief Medical Officer

Officer
3,021 -26.1%
8.00
US$24,168 		3,021 -26.1% 8.00 US$24,168
2019-12-26 2019-12-23 PlS Planned sale Orford Keith

Chief Medical Officer

Officer
3,021 -20.7%
6.00
US$18,126 		3,021 -20.7% 6.00 US$18,126
2019-11-22 2019-11-20 B Purchase BVF PARTNERS L P/IL Large shareholder
14,151 +2.1%
3.91
US$55,353 		14,151 +2.1% 3.91 US$55,353
2019-11-22 2019-11-20 B Purchase BVF PARTNERS L P/IL Large shareholder
79,285 +2.1%
3.91
US$310,131 		79,285 +2.1% 3.91 US$310,131
2019-11-22 2019-11-20 B Purchase BVF PARTNERS L P/IL Large shareholder
98,518 +2.1%
3.91
US$385,363 		98,518 +2.1% 3.91 US$385,363
2019-11-18 2019-11-14 B Purchase BVF PARTNERS L P/IL Large shareholder
11,105 +1.7%
3.37
US$37,424 		11,105 +1.7% 3.37 US$37,424
2019-11-18 2019-11-14 B Purchase BVF PARTNERS L P/IL Large shareholder
45,888 +1.2%
3.37
US$154,643 		45,888 +1.2% 3.37 US$154,643
2019-11-18 2019-11-14 B Purchase BVF PARTNERS L P/IL Large shareholder
71,495 +1.6%
3.37
US$240,938 		71,495 +1.6% 3.37 US$240,938
2019-10-31 2019-10-30 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
57,868 +9.8%
2.70
US$156,244 		57,868 +9.8% 2.70 US$156,244
2019-10-31 2019-10-30 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
331,048 +9.8%
2.70
US$893,830 		331,048 +9.8% 2.70 US$893,830
2019-10-31 2019-10-30 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
408,592 +9.8%
2.70
US$1,103,198 		408,592 +9.8% 2.70 US$1,103,198
2019-10-31 2019-10-29 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
116,552 +24.6%
2.60
US$303,035 		116,552 +24.6% 2.60 US$303,035
2019-10-31 2019-10-29 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
610,052 +22.1%
2.60
US$1,586,135 		610,052 +22.1% 2.60 US$1,586,135
2019-10-31 2019-10-29 B Purchase
4.0
BVF PARTNERS L P/IL
Large shareholder
872,373 +26.5%
2.60
US$2,268,170 		872,373 +26.5% 2.60 US$2,268,170
2019-06-27 2019-06-25 PP Planned purchase
Molineaux Christopher

SR. VP, DEVELOPMENT
51,600 +12.7%
3.88
US$200,208 		51,600 +12.7% 3.88 US$200,208
2019-06-27 2019-06-25 PP Planned purchase
Molineaux Susan

PRESIDENT AND CEO

Executive Director
51,600 +12.7%
3.88
US$200,208 		51,600 +12.7% 3.88 US$200,208
2019-06-19 2019-06-17 PlS Planned sale
Orford Keith

Chief Medical Officer
417 -3.3%
6.00
US$2,502 		417 -3.3% 6.00 US$2,502
2019-05-24 2019-05-22 PlS Planned sale
Orford Keith

Chief Medical Officer
416 -4.0%
6.00
US$2,496 		416 -4.0% 6.00 US$2,496
2019-04-17 2019-04-15 PlS Planned sale
Orford Keith

Chief Medical Officer
416 -3.8%
6.33
US$2,633 		416 -3.8% 6.33 US$2,633
2019-03-19 2019-03-15 PlS Planned sale
Orford Keith

Chief Medical Officer
417 -3.7%
6.43
US$2,681 		417 -3.7% 6.43 US$2,681
2019-03-13 2019-03-11 PlS Planned sale
Orford Keith

Chief Medical Officer

Officer
1,565 -12.2%
6.00
US$9,390 		1,565 -12.2% 6.00 US$9,390
2018-10-17 2018-10-15 PlS Planned sale Orford Keith

SR. VP, CLINICAL DEVELOPMENT

Officer
313 -2.9%
6.05
US$1,894 		313 -2.9% 6.05 US$1,894
2018-10-15 2018-10-11 PlS Planned sale Orford Keith

SR. VP, CLINICAL DEVELOPMENT

Officer
1,252 -10.5%
6.00
US$7,512 		1,252 -10.5% 6.00 US$7,512
2017-09-28 2017-09-28 S Sale ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
38,000 -1.1%
15.50
US$589,000 		38,000 -1.1% 15.50 US$589,000
2017-09-28 2017-09-27 S Sale ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
186,000 -4.9%
15.59
US$2,899,740 		186,000 -4.9% 15.59 US$2,899,740
2017-09-28 2017-09-26 S Sale ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
352,000 -8.5%
15.68
US$5,519,360 		352,000 -8.5% 15.68 US$5,519,360
2017-07-19 2017-07-17 PlS Planned sale Wong Stephanie

VP, FINANCE AND SECRETARY

Officer
3,552 -25.2%
18.41
US$65,385 		3,552 -25.2% 18.41 US$65,385
2017-07-19 2017-07-17 PlS Planned sale Orford Keith

SR. VP, CLINICAL DEVELOPMENT

Officer
2,120 -23.6%
18.31
US$38,823 		2,120 -23.6% 18.31 US$38,823
2017-07-07 2017-07-06 PlS Planned sale Hecht Curtis

SVP, BUS. & CORP. DEVELOPMENT

Officer
700 -4.2%
18.00
US$12,600 		700 -4.2% 18.00 US$12,600
2017-05-23 2017-05-19 PlS Planned sale Hecht Curtis

SVP, BUS. & CORP. DEVELOPMENT

Officer
650 -4.2%
16.00
US$10,400 		650 -4.2% 16.00 US$10,400
2017-03-24 2017-03-22 B Purchase ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
487,804 +13.4%
10.25
US$4,999,991 		487,804 +13.4% 10.25 US$4,999,991
2017-03-15 2017-03-13 PlS Planned sale Hecht Curtis

SVP, BUS. & CORP. DEVELOPMENT
600 -3.7%
14.00
US$8,400 		600 -3.7% 14.00 US$8,400
2017-03-06 2017-03-02 PlS Planned sale Hecht Curtis

See Remarks
550 -3.3%
12.00
US$6,600 		550 -3.3% 12.00 US$6,600
2016-11-17 2016-11-16 B Purchase ADAGE CAPITAL PARTNERS GP, L.L.C. Large shareholder
500,000 +15.9%
3.15
US$1,575,000 		500,000 +15.9% 3.15 US$1,575,000
2015-09-24 2015-09-23 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
40,168 +1.3%
6.07
US$243,768 		40,168 +1.3% 6.07 US$243,768
2015-09-24 2015-09-22 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
41,800 +1.4%
6.00
US$250,938 		41,800 +1.4% 6.00 US$250,938
2015-09-24 2015-09-22 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
25,000 +0.8%
6.00
US$149,942 		25,000 +0.8% 6.00 US$149,942
2015-09-08 2015-09-04 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
2,300 +0.1%
5.95
US$13,685 		2,300 +0.1% 5.95 US$13,685
2015-09-08 2015-09-03 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
88,000 +3.0%
5.93
US$521,840 		88,000 +3.0% 5.93 US$521,840
2015-08-28 2015-08-28 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
22,000 +0.8%
5.58
US$122,760 		22,000 +0.8% 5.58 US$122,760
2015-08-28 2015-08-28 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
20,700 +0.7%
5.55
US$114,885 		20,700 +0.7% 5.55 US$114,885
2015-08-28 2015-08-27 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
32,400 +1.1%
5.35
US$173,340 		32,400 +1.1% 5.35 US$173,340
2015-08-28 2015-08-27 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
29,089 +1.0%
5.17
US$150,390 		29,089 +1.0% 5.17 US$150,390
2015-08-28 2015-08-27 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
19,578 +0.7%
5.58
US$109,245 		19,578 +0.7% 5.58 US$109,245
2015-08-28 2015-08-27 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
6,253 +0.2%
5.43
US$33,954 		6,253 +0.2% 5.43 US$33,954
2015-08-28 2015-08-27 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
9,848 +0.4%
5.41
US$53,278 		9,848 +0.4% 5.41 US$53,278
2015-08-28 2015-08-26 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
32,058 +1.2%
4.65
US$149,070 		32,058 +1.2% 4.65 US$149,070
2015-08-28 2015-08-26 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
200 +0.0%
4.70
US$940 		200 +0.0% 4.70 US$940
2014-10-15 2014-10-15 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
25,000 +0.9%
6.80
US$170,000 		25,000 +0.9% 6.80 US$170,000
2014-10-15 2014-10-15 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
13,000 +0.5%
7.25
US$94,250 		13,000 +0.5% 7.25 US$94,250
2014-10-15 2014-10-14 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
25,000 +0.9%
6.99
US$174,750 		25,000 +0.9% 6.99 US$174,750
2014-10-15 2014-10-14 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
30,000 +1.1%
7.00
US$210,000 		30,000 +1.1% 7.00 US$210,000
2014-10-15 2014-10-13 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
88,700 +3.4%
6.94
US$615,578 		88,700 +3.4% 6.94 US$615,578
2014-10-09 2014-10-07 B Purchase Delphi Management Partners VIII, L.L.C. Large shareholder
4,835 +26.0%
10.00
US$48,350 		4,835 +26.0% 10.00 US$48,350
2014-10-09 2014-10-07 B Purchase Delphi Management Partners VIII, L.L.C. Large shareholder
495,165 +26.0%
10.00
US$4,951,650 		495,165 +26.0% 10.00 US$4,951,650
2014-10-09 2014-10-07 B Purchase George Jean Non-Executive Director Large shareholder
300,000 +16.6%
10.00
US$3,000,000 		300,000 +16.6% 10.00 US$3,000,000
2014-10-09 2014-10-07 B Purchase MORGENTHALER VENTURE PARTNERS IX LP Large shareholder
350,000 +19.3%
10.00
US$3,500,000 		350,000 +19.3% 10.00 US$3,500,000
2014-10-09 2014-10-07 B Purchase Christoffersen Ralph E Non-Executive Director Large shareholder
350,000 +19.3%
10.00
US$3,500,000 		350,000 +19.3% 10.00 US$3,500,000
2014-10-09 2014-10-07 B Purchase Advanced Technology Ventures VIII LP Large shareholder
300,000 +16.6%
10.00
US$3,000,000 		300,000 +16.6% 10.00 US$3,000,000
2014-10-09 2014-10-07 B Purchase PAKIANATHAN DEEPIKA Non-Executive Director Large shareholder
4,835 +26.0%
10.00
US$48,350 		4,835 +26.0% 10.00 US$48,350
2014-10-09 2014-10-07 B Purchase PAKIANATHAN DEEPIKA Non-Executive Director Large shareholder
495,165 +26.0%
10.00
US$4,951,650 		495,165 +26.0% 10.00 US$4,951,650
2014-10-03 2014-10-01 B Purchase ADAGE CAPITAL PARTNERS GP LLC Large shareholder
800,000 +44.9%
10.00
US$8,000,000 		800,000 +44.9% 10.00 US$8,000,000
Explore more

More insider trading research around Calithera Biosciences Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America